Shares ofMerck & Co., Inc. (NYSE:MRK) fell sharply during Tuesday's session after the company reported second-quarter financial results and cut its FY24 adjusted EPS guidance below estimates.

Merck reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15, according to data from Benzinga Pro.

Merck shares dipped 9.5% to $115.50 on Tuesday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Imunon, Inc. (NASDAQ:IMNN) shares...